Related Content
March 21, 2018 โ Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) ...
November 8, 2017 โ New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report ...
November 1, 2017 โ OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
October 26, 2015 โ OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient ...
May 28, 2015 โ OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized ...
March 6, 2015 โ A three-year review of data on the Combo Dual Therapy Stent was presented at the Joint Interventional ...
July 30, 2014 โ OrbusNeich announced the first patient has been enrolled in the Multinational Abluminal Sirolimus Coated ...
June 24, 2014 โ OrbusNeich announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE ...
May 14, 2014 โ OrbusNeich announced the launch of the Sapphire II NC coronary dilatation catheter, a non-compliant ...